Biological Activity of Picrorhiza kurroa: A Source of Potential Antimicrobial Compounds against Yersinia enterocolitica.
- Thapa A et al (2022).
- Int J Mol Sci.
- PubMed:
- 36430568
Scientists evaluated Codonopsis lanceolata as a potential treatment for COVID-19 and found that the plant extract and its active compound, lancemaside A (LA), effectively blocked SARS-CoV-2 infection by altering membrane cholesterol and blocking membrane fusion between the virus and host cells. LA also impeded the entry pathways of several SARS-CoV-2 variants, including Omicron. Researchers suggest that LA has broad-spectrum anti-SARS-CoV-2 activity and may serve as a potential therapeutic option.